Trials / Completed
CompletedNCT03556722
Transcranial Magnetic Stimulation in Episodic Migraine (Magnet-EM)
Effectiveness and Tolerability of Repetitive Transcranial Magnetic Stimulation For Preventive Treatment Of Episodic Migraine: A Single Centre, Randomised, Double-Blind, Sham-Controlled Phase 2 Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- Universiti Putra Malaysia · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) as new preventive treatment of migraine.
Detailed description
Migraine patients according to International Headache Society criteria will be allocated randomly into two treatment arms. One group will receive active rTMS and another group will receive sham rTMS for treatment phase (5 sessions). Assessment will be made at baseline, month 1, month 2 and month 3 post-treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Repetitive Transcranial Magnetic Stimulation. | High frequency rTMS on left dorsolateral prefrontal cortex. |
| DEVICE | Sham rTMS | Sham rTMS without active magnetic coil on left dorsolateral prefrontal cortex. |
Timeline
- Start date
- 2019-04-15
- Primary completion
- 2021-02-04
- Completion
- 2022-04-01
- First posted
- 2018-06-14
- Last updated
- 2022-11-02
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT03556722. Inclusion in this directory is not an endorsement.